{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:06:22Z","timestamp":1792670782250,"version":"4.5.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T00:00:00Z","timestamp":1435968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00281-015-0507-3","type":"journal-article","created":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T09:24:29Z","timestamp":1435915469000},"page":"463-473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Environmental risk factors of systemic sclerosis"],"prefix":"10.1007","volume":"37","author":[{"given":"Isabelle","family":"Marie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Gehanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,4]]},"reference":[{"key":"507_CR1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/apt.12818","volume":"40","author":"I Marie","year":"2014","unstructured":"Marie I, Antonietti M, Houivet E, Hachulla E, Maunoury V, Bienvenu B, Viennot S, Smail A, Duhaut P, Dupas JL, Dominique S, Hatron PY, Levesque H, Benichou J, Ducrott\u00e9 P (2014) Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis. Aliment Pharmacol Ther 40:189\u2013199","journal-title":"Aliment Pharmacol Ther"},{"key":"507_CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.autrev.2013.10.002","volume":"13","author":"I Marie","year":"2014","unstructured":"Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, Bravard P, No\u00ebl D, Cailleux AF, Weber J, Lagoutte P, Benichou J, Levesque H (2014) Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev 13:151\u2013156","journal-title":"Autoimmun Rev"},{"key":"507_CR3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.autrev.2015.01.018","volume":"14","author":"I Marie","year":"2015","unstructured":"Marie I, Leroi AM, Menard JF, Levesque H, Quillard M, Ducrotte P (2015) Fecal calprotectin in systemic sclerosis and review of the literature. Autoimmun Rev 14:547\u2013554","journal-title":"Autoimmun Rev"},{"key":"507_CR4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaad.2014.11.027","volume":"72","author":"I Marie","year":"2015","unstructured":"Marie I, Menard JF, Duval-Modeste AB, Joly P, Dominique S, Bravard P, No\u00ebl D, Gehanno JF, Bubenheim M, Benichou J, Levesque H (2015) Association of occupational exposure with features of systemic sclerosis. J Am Acad Dermatol 72:456\u2013464","journal-title":"J Am Acad Dermatol"},{"key":"507_CR5","doi-asserted-by":"crossref","unstructured":"Altorok N, Almeshal N, Wang Y, Kahaleh B (2014) Epigenetics, the holy grail in the pathogenesis of systemic sclerosis. Rheumatology (Oxford) Apr 16","DOI":"10.1093\/rheumatology\/keu155"},{"key":"507_CR6","author":"M Ciechomska","year":"2015","unstructured":"Ciechomska M, van Laar J, O\u2019Reilly S (2015) Current frontiers in systemic sclerosis pathogenesis. Exp Dermatol. doi: 10.1111\/exd.12673","journal-title":"Exp Dermatol"},{"key":"507_CR7","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1046\/j.1523-1747.2002.19614.x","volume":"119","author":"I Marie","year":"2002","unstructured":"Marie I, B\u00e9ny JL (2002) Endothelial dysfunction in murine model of systemic sclerosis: tight-skin mice 1. J Invest Dermatol 119:1379\u201387","journal-title":"J Invest Dermatol"},{"key":"507_CR8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","volume":"370","author":"L Bon van","year":"2014","unstructured":"van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, Farina GA, Stifano G, Mathes AL, Cossu M, York M, Collins C, Wenink M, Huijbens R, Hesselstrand R, Saxne T, DiMarzio M, Wuttge D, Agarwal SK, Reveille JD, Assassi S, Mayes M, Deng Y, Drenth JP, de Graaf J, den Heijer M, Kallenberg CG, Bijl M, Loof A, van den Berg WB, Joosten LA, Smith V, de Keyser F, Scorza R, Lunardi C, van Riel PL, Vonk M, van Heerde W, Meller S, Homey B, Beretta L, Roest M, Trojanowska M, Lafyatis R, Radstake TR (2014) Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med 370:433\u2013443","journal-title":"N Engl J Med"},{"key":"507_CR9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/gene.2014.44","volume":"15","author":"M Ciechomska","year":"2014","unstructured":"Ciechomska M, van Laar JM, O\u2019Reilly S (2014) Emerging role of epigenetics in systemic sclerosis pathogenesis. Genes Immun 15:433\u2013439","journal-title":"Genes Immun"},{"key":"507_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaut.2013.01.012","volume":"41","author":"Y Luo","year":"2013","unstructured":"Luo Y, Wang Y, Wang Q, Xiao R, Lu Q (2013) Systemic sclerosis: genetics and epigenetics. J Autoimmun 41:161\u2013167","journal-title":"J Autoimmun"},{"key":"507_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.01.010","volume":"41","author":"Q Lu","year":"2013","unstructured":"Lu Q (2013) The critical importance of epigenetics in autoimmunity. J Autoimmun 41:1\u20135","journal-title":"J Autoimmun"},{"key":"507_CR12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/03009740902758875","volume":"38","author":"W Lei","year":"2009","unstructured":"Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, Li Y, Qiu X, Zhou Y, Long H, Zhao M, Liang Y, Su Y, Lu Q (2009) Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 38:369\u2013374","journal-title":"Scand J Rheumatol"},{"key":"507_CR13","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.34376","volume":"64","author":"X Lian","year":"2012","unstructured":"Lian X, Xiao R, Hu X, Kanekura T, Jiang H, Li Y, Wang Y, Yang Y, Zhao M, Lu Q (2012) DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility. Arthritis Rheum 64:2338\u20132345","journal-title":"Arthritis Rheum"},{"key":"507_CR14","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/jcmm.12105","volume":"17","author":"Y Wang","year":"2013","unstructured":"Wang Y, Kahaleh B (2013) Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma. J Cell Mol Med 17:1291\u20131299","journal-title":"J Cell Mol Med"},{"key":"507_CR15","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/jid.2012.479","volume":"133","author":"AK Ghosh","year":"2013","unstructured":"Ghosh AK, Bhattacharyya S, Lafyatis R, Farina G, Yu J, Thimmapaya B, Wei J, Varga J (2013) p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-\u03b2: epigenetic feed-forward amplification of fibrosis. J Invest Dermatol 133:1302\u20131310","journal-title":"J Invest Dermatol"},{"key":"507_CR16","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/art.39061","volume":"67","author":"J Wei","year":"2015","unstructured":"Wei J, Ghosh AK, Chu H, Fang F, Hinchcliff ME, Wang J, Marangoni RG, Varga J (2015) The histone deacetylase sirtuin 1 is reduced in systemic sclerosis and abrogates fibrotic responses by targeting transforming growth factor \u03b2 signaling. Arthritis Rheumatol 67:1323\u20131334","journal-title":"Arthritis Rheumatol"},{"key":"507_CR17","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","volume":"51","author":"S O\u2019Reilly","year":"2012","unstructured":"O\u2019Reilly S, H\u00fcgle T, van Laar JM (2012) T cells in systemic sclerosis: a reappraisal. Rheumatology (Oxford) 51:1540\u20131549","journal-title":"Rheumatology (Oxford)"},{"key":"507_CR18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaut.2012.05.007","volume":"39","author":"C Selmi","year":"2012","unstructured":"Selmi C, Leung PS, Sherr DH, Diaz M, Nyland JF, Monestier M, Rose NR, Gershwin ME (2012) Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun 39:272\u2013284","journal-title":"J Autoimmun"},{"key":"507_CR19","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/exd.12245","volume":"22","author":"R Takemoto","year":"2013","unstructured":"Takemoto R, Jinnin M, Wang Z, Kudo H, Inoue K, Nakayama W, Ichihara A, Igata T, Kajihara I, Fukushima S, Ihn H (2013) Hair miR-29a levels are decreased in patients with scleroderma. Exp Dermatol 22:832\u2013833","journal-title":"Exp Dermatol"},{"key":"507_CR20","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","volume":"188","author":"T Nakashima","year":"2012","unstructured":"Nakashima T, Jinnin M, Yamane K, Honda N, Kajihara I, Makino T, Masuguchi S, Fukushima S, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H (2012) Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts. J Immunol 188:3573\u20133583","journal-title":"J Immunol"},{"key":"507_CR21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1586\/eci.11.37","volume":"7","author":"A J\u00fcngel","year":"2011","unstructured":"J\u00fcngel A, Distler JH, Gay S, Distler O (2011) Epigenetic modifications: novel therapeutic strategies for systemic sclerosis? Expert Rev Clin Immunol 7:475\u2013480","journal-title":"Expert Rev Clin Immunol"},{"key":"507_CR22","first-page":"387","volume":"12","author":"B Bramwell","year":"1914","unstructured":"Bramwell B (1914) Diffuse scleroderma: its frequency and occurrence in stonemasons; its treatment by fibrinolysin: elevations of temperature due to fibrinolysin injections. Edinburg Med J 12:387","journal-title":"Edinburg Med J"},{"key":"507_CR23","first-page":"209","volume":"3","author":"LD Erasmus","year":"1957","unstructured":"Erasmus LD (1957) Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations. S Afr Lab Clin Med 3:209\u2013231","journal-title":"S Afr Lab Clin Med"},{"key":"507_CR24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/oem.60.2.122","volume":"60","author":"GM Calvert","year":"2003","unstructured":"Calvert GM, Rice FL, Boiano JM, Sheehy JW, Sanderson WT (2003) Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 60:122\u2013129","journal-title":"Occup Environ Med"},{"key":"507_CR25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/oem.59.8.545","volume":"59","author":"E Diot","year":"2002","unstructured":"Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Rogier S, Stadler M, Diot P, Lemarie E, Lasfargues G (2002) Systemic sclerosis and occupational risk factors: a case\u2013control study. Occup Environ Med 59:545\u2013549","journal-title":"Occup Environ Med"},{"key":"507_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1445-5994.2000.tb00810.x","volume":"30","author":"H Englert","year":"2000","unstructured":"Englert H, O\u2019connor H, Small-McMahon J, Chambers P, Davis K, Brooks P (2000) Male systemic sclerosis and occupational silica exposure\u2014a population based study. Aust N Z J Med 30:215\u2013220","journal-title":"Aust N Z J Med"},{"key":"507_CR27","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/ard.51.12.1322","volume":"51","author":"AJ Silman","year":"1992","unstructured":"Silman AJ, Jones S (1992) What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis 51:1322\u20131324","journal-title":"Ann Rheum Dis"},{"key":"507_CR28","first-page":"838","volume":"41","author":"GK Sluis-Cremer","year":"1985","unstructured":"Sluis-Cremer GK, Hassel PA, Nizdo EH, Churchill AR, Zeiss EA (1985) Silica, silicosis and progressive systemic sclerosis. Br J Ind Med 41:838\u2013843","journal-title":"Br J Ind Med"},{"key":"507_CR29","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0190-9622(90)70062-M","volume":"22","author":"UF Haustein","year":"1990","unstructured":"Haustein UF, Ziegler V, Hermann K, Mehlhorn J, Schmidt C (1990) Silica-induced scleroderma. J Am Acad Dermatol 22:444\u2013448","journal-title":"J Am Acad Dermatol"},{"key":"507_CR30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jaut.2012.05.002","volume":"39","author":"FW Miller","year":"2012","unstructured":"Miller FW, Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, Norris JM, De Roos AJ (2012) Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun 39:259\u2013271","journal-title":"J Autoimmun"},{"key":"507_CR31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jbspin.2010.02.044","volume":"77","author":"S Moisan","year":"2010","unstructured":"Moisan S, Rucay P, Ghali A, Penneau-Fontbonne D, Lavigne C (2010) Silica-associated limited systemic sclerosis after occupational exposure to calcined diatomaceous earth. Joint Bone Spine 77:472\u2013473","journal-title":"Joint Bone Spine"},{"key":"507_CR32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/1547691X.2010.512579","volume":"7","author":"M Maeda","year":"2010","unstructured":"Maeda M, Nishimura Y, Kumagai N, Hayashi H, Hatayama T, Katoh M, Miyahara N, Yamamoto S, Hirastuka J, Otsuki T (2010) Dysregulation of the immune system caused by silica and asbestos. J Immunotoxicol 7:268\u2013278","journal-title":"J Immunotoxicol"},{"key":"507_CR33","first-page":"261","volume":"4","author":"T Otsuki","year":"2007","unstructured":"Otsuki T, Maeda M, Murakami S, Hayashi H, Miura Y, Kusaka M, Nakano T, Fukuoka K, Kishimoto T, Hyodoh F, Ueki A, Nishimura Y (2007) Immunological effects of silica and asbestos. Cell Mol Immunol 4:261\u2013268","journal-title":"Cell Mol Immunol"},{"key":"507_CR34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.imbio.2011.12.009","volume":"217","author":"S Lee","year":"2012","unstructured":"Lee S, Hayashi H, Maeda M, Chen Y, Matsuzaki H, Takei-Kumagai N, Nishimura Y, Fujimoto W, Otsuki T (2012) Environmental factors producing autoimmune dysregulation\u2014chronic activation of T cells caused by silica exposure. Immunobiology 217:743\u2013748","journal-title":"Immunobiology"},{"key":"507_CR35","first-page":"11S","volume":"24","author":"T Otsuki","year":"2011","unstructured":"Otsuki T, Hayashi H, Nishimura Y, Hyodo F, Maeda M, Kumagai N, Miura Y, Kusaka M, Uragami K (2011) Dysregulation of autoimmunity caused by silica exposure and alteration of Fas-mediated apoptosis in T lymphocytes derived from silicosis patients. Int J Immunopathol Pharmacol 24:11S\u201316S","journal-title":"Int J Immunopathol Pharmacol"},{"key":"507_CR36","first-page":"782045","volume":"2014","author":"JC Pfau","year":"2014","unstructured":"Pfau JC, Serve KM, Noonan CW (2014) Autoimmunity and asbestos exposure. Autoimmune Dis 2014:782045","journal-title":"Autoimmune Dis"},{"key":"507_CR37","first-page":"274","volume":"98","author":"SK Nigam","year":"1993","unstructured":"Nigam SK, Suthar AM, Patel MM, Karnik AB, Dave SK, Kashyap SK, Venkaiah K (1993) Humoral immunological profile of workers exposed to asbestos in asbestos mines. Indian J Med Res 98:274\u2013277","journal-title":"Indian J Med Res"},{"key":"507_CR38","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1289\/ehp.9203","volume":"114","author":"CW Noonan","year":"2006","unstructured":"Noonan CW, Pfau JC, Larson TC, Spence MR (2006) Nested case\u2013control study of autoimmune disease in an asbestos-exposed population. Environ Health Perspect 114:1243\u20131247","journal-title":"Environ Health Perspect"},{"key":"507_CR39","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1002\/art.22880","volume":"56","author":"LS Gold","year":"2007","unstructured":"Gold LS, Ward MH, Dosemeci M, De Roos AJ (2007) Systemic autoimmune disease mortality and occupational exposures. Arthritis Rheum 56:3189\u20133201","journal-title":"Arthritis Rheum"},{"key":"507_CR40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/1547691X.2013.847510","volume":"11","author":"A Ferro","year":"2014","unstructured":"Ferro A, Zebedeo CN, Davis C, Ng KW, Pfau JC (2014) Amphibole, but not chrysotile, asbestos induces anti-nuclear autoantibodies and IL-17 in C57BL\/6 mice. J Immunotoxicol 11:283\u2013290","journal-title":"J Immunotoxicol"},{"key":"507_CR41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/1547691X.2012.747230","volume":"10","author":"KD Salazar","year":"2013","unstructured":"Salazar KD, Copeland CB, Wood CE, Schmid JE, Luebke RW (2013) Evaluation of anti-nuclear antibodies and kidney pathology in Lewis rats following exposure to Libby amphibole asbestos. J Immunotoxicol 10:329\u2013333","journal-title":"J Immunotoxicol"},{"key":"507_CR42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/15287394.2012.668164","volume":"75","author":"KD Salazar","year":"2012","unstructured":"Salazar KD, Copeland CB, Luebke RW (2012) Effects of Libby amphibole asbestos exposure on two models of arthritis in the Lewis rat. J Toxicol Environ Health 75:351\u2013365","journal-title":"J Toxicol Environ Health"},{"key":"507_CR43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.autrev.2006.10.002","volume":"6","author":"J Furuzawa-Carballeda","year":"2007","unstructured":"Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR (2007) Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6:169\u2013175","journal-title":"Autoimmun Rev"},{"key":"507_CR44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","volume":"148","author":"B Afzali","year":"2007","unstructured":"Afzali B, Lombardi G, Lechler RI, Lord GM (2007) The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 148:32\u2013346","journal-title":"Clin Exp Immunol"},{"key":"507_CR45","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00296-011-2056-y","volume":"32","author":"TS Rodr\u00edguez-Reyna","year":"2012","unstructured":"Rodr\u00edguez-Reyna TS, Furuzawa-Carballeda J, Cabiedes J, Fajardo-Hermosillo LD, Mart\u00ednez-Reyes C, D\u00edaz-Zamudio M, Llorente L (2012) Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study. Rheumatol Int 32:2653\u20132660","journal-title":"Rheumatol Int"},{"key":"507_CR46","first-page":"58","volume":"7","author":"W Reinl","year":"1957","unstructured":"Reinl W (1957) Sklerodermie durch trichlor\u00e4thylen-einwirkung? Zent F Arbeitsmd u Arbettsschutz 7:58\u201360","journal-title":"Zent F Arbeitsmd u Arbettsschutz"},{"key":"507_CR47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00420-003-0462-5","volume":"77","author":"M Bovenzi","year":"2004","unstructured":"Bovenzi M, Barbone F, Pisa FE, Betta A, Romeo L, Tonello A, Biasi D, Caramaschi P (2004) A case\u2013control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 77:10\u201316","journal-title":"Int Arch Occup Environ Health"},{"key":"507_CR48","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/aje\/kwf223","volume":"157","author":"DH Garabrant","year":"2003","unstructured":"Garabrant DH, Lacey JV Jr, Laing TJ, Gillepsie BW, Mayes MD, Cooper BC (2003) Scleroderma and solvent exposure among women. Am J Epidemiol 157:493\u2013500","journal-title":"Am J Epidemiol"},{"key":"507_CR49","first-page":"97","volume":"34","author":"A Kettaneh","year":"2007","unstructured":"Kettaneh A, Al Moufti O, Tiev KP, Chayet C, Toledano C, Fabre B, Fardet L, Cabane J (2007) Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case\u2013control studies. J Rheumatol 34:97\u2013103","journal-title":"J Rheumatol"},{"key":"507_CR50","first-page":"2395","volume":"31","author":"A Ma\u00eetre","year":"2004","unstructured":"Ma\u00eetre A, Hours M, Bonneterre V, Arnaud J, T\u00fclin-Arslan M, Carpentier P, Bergeret A, de Gaudemaris R (2004) Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J Rheumatol 31:2395\u20132401","journal-title":"J Rheumatol"},{"key":"507_CR51","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/1529-0131(199806)41:6<1111::AID-ART19>3.0.CO;2-J","volume":"41","author":"PJ Nietert","year":"1998","unstructured":"Nietert PJ, Sutherland SE, Silver RM, Pandey JP, Knapp RG, Hoel DG, Dosemeci M (1998) Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 41:1111\u20131118","journal-title":"Arthritis Rheum"},{"key":"507_CR52","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1289\/ehp.11782","volume":"117","author":"GS Cooper","year":"2009","unstructured":"Cooper GS, Makris SL, Nietert PJ, Jinot J (2009) Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans. Environ Health Perspect 117:696\u2013702","journal-title":"Environ Health Perspect"},{"key":"507_CR53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/taap.1995.1179","volume":"134","author":"MF Khan","year":"1995","unstructured":"Khan MF, Kaphalia BS, Prabhakar BS, Kanz MF, Ansari GA (1995) Trichloroethene-induced autoimmune response in female MRL +\/+ mice. Toxicol Appl Pharmacol 134:155\u2013160","journal-title":"Toxicol Appl Pharmacol"},{"key":"507_CR54","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.taap.2007.01.020","volume":"220","author":"P Cai","year":"2007","unstructured":"Cai P, K\u00f6nig R, Khan MF, Kaphalia BS, Ansari GA (2007) Differential immune responses to albumin adducts of reactive intermediates of trichloroethene in MRL+\/+ mice. Toxicol Appl Pharmacol 220:278\u2013283","journal-title":"Toxicol Appl Pharmacol"},{"key":"507_CR55","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0891-5849(96)00586-2","volume":"23","author":"T Grune","year":"1997","unstructured":"Grune T, Michel P, Sitte N, Eggert W, Albrecht-Nebe H, Esterbauer H, Siems WG (1997) Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free Radic Biol Med 23:357\u2013360","journal-title":"Free Radic Biol Med"},{"key":"507_CR56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0378-4274(97)00053-2","volume":"92","author":"NC Halmes","year":"1997","unstructured":"Halmes NC, Perkins EJ, McMillan DC, Pumford NR (1997) Detection of trichloroethylene-protein adducts in rat liver and plasma. Toxicol Lett 92:187\u2013194","journal-title":"Toxicol Lett"},{"key":"507_CR57","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1080\/15287390701550888","volume":"70","author":"G Wang","year":"2007","unstructured":"Wang G, Ansari GA, Khan MF (2007) Involvement of lipid peroxidation-derived aldehyde-protein adducts in autoimmunity mediated by trichloroethene. J Toxicol Environ Health 70:1977\u20131985","journal-title":"J Toxicol Environ Health"},{"key":"507_CR58","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.freeradbiomed.2008.01.012","volume":"44","author":"G Wang","year":"2008","unstructured":"Wang G, K\u00f6nig R, Ansari GA, Khan MF (2008) Lipid peroxidation-derived aldehyde-protein adducts contribute to trichloroethene-mediated autoimmunity via activation of CD4+ T cells. Free Radic Biol Med 44:1475\u20131482","journal-title":"Free Radic Biol Med"},{"key":"507_CR59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tox.2011.12.001","volume":"292","author":"G Wang","year":"2012","unstructured":"Wang G, Wang J, Fan X, Ansari GA, Khan MF (2012) Protein adducts of malondialdehyde and 4-hydroxynonenal contribute to trichloroethene-mediated autoimmunity via activating Th17 cells: dose- and time-response studies in female MRL+\/+ mice. Toxicology 292:113\u2013122","journal-title":"Toxicology"},{"key":"507_CR60","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tox.2007.07.006","volume":"239","author":"T Shen","year":"2007","unstructured":"Shen T, Zhu QX, Yang S, Ding R, Ma T, Ye LP, Wang LJ, Liang ZZ, Zhang XJ (2007) Trichloroethylene induce nitric oxide production and nitric oxide synthase mRNA expression in cultured normal human epidermal keratinocytes. Toxicology 239:186\u2013194","journal-title":"Toxicology"},{"key":"507_CR61","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0162-3109(99)00164-2","volume":"46","author":"JM Griffin","year":"2000","unstructured":"Griffin JM, Blossom SJ, Jackson SK, Gilbert KM, Pumford NR (2000) Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL +\/+ mice. Immunopharmacology 46:123\u2013137","journal-title":"Immunopharmacology"},{"key":"507_CR62","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/15476910701337035","volume":"4","author":"SJ Blossom","year":"2007","unstructured":"Blossom SJ, Doss JC (2007) Trichloroethylene alters central and peripheral immune function in autoimmune-prone MRL(+\/+) mice following continuous developmental and early life exposure. J Immunotoxicol 4:129\u2013141","journal-title":"J Immunotoxicol"},{"key":"507_CR63","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12012-011-9113-3","volume":"11","author":"B Palbykin","year":"2011","unstructured":"Palbykin B, Borg J, Caldwell PT, Rowles J, Papoutsis AJ, Romagnolo DF, Selmin OI (2011) Trichloroethylene induces methylation of the Serca2 promoter in H9c2 cells and embryonic heart. Cardiovasc Toxicol 11:204\u2013214","journal-title":"Cardiovasc Toxicol"},{"key":"507_CR64","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1080\/15287390802114600","volume":"71","author":"ML Olsgard","year":"2008","unstructured":"Olsgard ML, Bortolotti GR, Trask BR, Smits JE (2008) Effects of inhalation exposure to a binary mixture of benzene and toluene on vitamin a status and humoral and cell-mediated immunity in wild and captive American kestrels. J Toxicol Environ Health 71:1100\u20131108","journal-title":"J Toxicol Environ Health"},{"key":"507_CR65","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1102443","volume":"306","author":"Q Lan","year":"2004","unstructured":"Lan Q, Zhang L, Li G, Vermeulen R, Weinberg RS, Dosemeci M, Rappaport SM, Shen M, Alter BP, Wu Y, Kopp W, Waidyanatha S, Rabkin C, Guo W, Chanock S, Hayes RB, Linet M, Kim S, Yin S, Rothman N, Smith MT (2004) Hematotoxicity in workers exposed to low levels of benzene. Science 306:1774\u20131776","journal-title":"Science"},{"key":"507_CR66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/15476910802019029","volume":"5","author":"AM Emara","year":"2008","unstructured":"Emara AM, El-Bahrawy H (2008) Green tea attenuates benzene-induced oxidative stress in pump workers. J Immunotoxicol 5:69\u201380","journal-title":"J Immunotoxicol"},{"key":"507_CR67","first-page":"191","volume":"3","author":"HJ Park","year":"2008","unstructured":"Park HJ, Oh JH, Yoon S, Rana SV (2008) Time dependent gene expression changes in the liver of mice treated with benzene. Biomark Insights 3:191\u2013201","journal-title":"Biomark Insights"},{"key":"507_CR68","first-page":"1928","volume":"31","author":"GS Cooper","year":"2004","unstructured":"Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Dooley MA (2004) Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol 31:1928\u20131933","journal-title":"J Rheumatol"},{"key":"507_CR69","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.annepidem.2005.08.001","volume":"15","author":"AJ Roos De","year":"2005","unstructured":"De Roos AJ, Cooper GS, Alavanja MC, Sandler DP (2005) Rheumatoid arthritis among women in the agricultural health study: risk associated with farming activities and exposures. Ann Epidemiol 15:762\u2013770","journal-title":"Ann Epidemiol"},{"key":"507_CR70","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1021\/es0716554","volume":"42","author":"DS Su","year":"2008","unstructured":"Su DS, Serafino A, M\u00fcller JO, Jentoft RE, Schl\u00f6gl R, Fiorito S (2008) Cytotoxicity and inflammatory potential of soot particles of low-emission diesel engines. Environ Sci Technol 42:1761\u20131765","journal-title":"Environ Sci Technol"},{"key":"507_CR71","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1016\/j.carbon.2011.07.022","volume":"49","author":"S Fiorito","year":"2011","unstructured":"Fiorito S, Mastrofrancesco A, Cardinali G, Rosato E, Salsano F, Su DS, Serafino A, Picardo M (2011) Effects of carbonaceous nanoparticles from low-emission and older diesel engines on human skin cells. Carbon 49:5038\u20135048","journal-title":"Carbon"},{"key":"507_CR72","doi-asserted-by":"crossref","first-page":"138751","DOI":"10.1155\/2014\/138751","volume":"2014","author":"A Mastrofrancesco","year":"2014","unstructured":"Mastrofrancesco A, Alf\u00e8 M, Rosato E, Gargiulo V, Beatrice C, Di Blasio G, Zhang B, Su DS, Picardo M, Fiorito S (2014) Proinflammatory effects of diesel exhaust nanoparticles on scleroderma skin cells. J Immunol Res 2014:138751","journal-title":"J Immunol Res"},{"key":"507_CR73","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1038\/jid.2010.120","volume":"130","author":"N Aden","year":"2010","unstructured":"Aden N, Nuttall A, Shiwen X, de Winter P, Leask A, Black CM, Denton CP, Abraham DJ, Stratton RJ (2010) Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis. J Invest Dermatol 130:2191\u20132200","journal-title":"J Invest Dermatol"},{"key":"507_CR74","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1002\/art.30492","volume":"63","author":"P Chaudhary","year":"2011","unstructured":"Chaudhary P, Chen X, Assassi S, Gorlova O, Draeger H, Harper BE, Gonzalez E, McNearney T, Perry M, Arnett FC, Mayes MD (2011) Cigarette smoking is not a risk factor for systemic sclerosis. Arthritis Rheum 63:3098\u20133102","journal-title":"Arthritis Rheum"},{"key":"507_CR75","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/art.30352","volume":"63","author":"P Hissaria","year":"2011","unstructured":"Hissaria P, Roberts-Thomson PJ, Lester S, Ahern MJ, Smith MD, Walker JG (2011) Cigarette smoking in patients with systemic sclerosis reduces overall survival: comment on the article by Hudson et al. Arthritis Rheum 63:1758\u20131759","journal-title":"Arthritis Rheum"},{"key":"507_CR76","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/acr.20416","volume":"63","author":"M Hudson","year":"2011","unstructured":"Hudson M, Lo E, Baron M, Steele R, Canadian Scleroderma Research Group (2011) Modeling smoking in systemic sclerosis: a comparison of different statistical approaches. Arthritis Care Res (Hoboken) 63:570\u2013578","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"507_CR77","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00296-012-2481-6","volume":"33","author":"G Gyger","year":"2013","unstructured":"Gyger G, Hudson M, Lo E, Steele R, Canadian Scleroderma Research Group (CSRG), Baron M (2013) Does cigarette smoking mitigate the severity of skin disease in systemic sclerosis? Rheumatol Int 33:943\u2013948","journal-title":"Rheumatol Int"},{"key":"507_CR78","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0378-4274(99)00220-9","volume":"112\u2013113","author":"D D\u2019Cruz","year":"2000","unstructured":"D\u2019Cruz D (2000) Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 112\u2013113:421\u201332","journal-title":"Toxicol Lett"},{"key":"507_CR79","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.clindermatol.2005.01.019","volume":"23","author":"UF Haustein","year":"2005","unstructured":"Haustein UF (2005) Scleroderma and pseudo-scleroderma: uncommon presentations. Clin Dermatol 23:480\u2013490","journal-title":"Clin Dermatol"},{"key":"507_CR80","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1085-5629(98)80064-3","volume":"17","author":"S Jablonska","year":"1998","unstructured":"Jablonska S, Blaszczyk M (1998) Scleroderma-like disorders. Semin Cutan Med Surg 17:65\u201376","journal-title":"Semin Cutan Med Surg"},{"key":"507_CR81","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00002018-200023040-00002","volume":"23","author":"P Vergne","year":"2000","unstructured":"Vergne P, Bertin P, Bonnet C, Scotto C, Tr\u00e8ves R (2000) Drug-induced rheumatic disorders: incidence, prevention and management. Drug Saf 23:279\u2013293","journal-title":"Drug Saf"},{"key":"507_CR82","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0961203311430703","volume":"21","author":"M Lidar","year":"2012","unstructured":"Lidar M, Agmon-Levin N, Langevitz P, Shoenfeld Y (2012) Silicone and scleroderma revisited. Lupus 21:121\u2013127","journal-title":"Lupus"},{"key":"507_CR83","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/archinte.1993.00410230048007","volume":"153","author":"AJ Bridges","year":"1993","unstructured":"Bridges AJ, Vasey FB (1993) Silicone breast implants. History, safety, and potential complications. Arch Intern Med 153:2638\u20132644","journal-title":"Arch Intern Med"},{"key":"507_CR84","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM200003163421105","volume":"342","author":"EC Janowsky","year":"2000","unstructured":"Janowsky EC, Kupper LL, Hulka BS (2000) Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 342:781\u2013790","journal-title":"N Engl J Med"},{"key":"507_CR85","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2230.2004.01668.x","volume":"30","author":"DT Alexandrescu","year":"2005","unstructured":"Alexandrescu DT, Bhagwati NS, Wiernik PH (2005) Chemotherapy-induced scleroderma: a pleiomorphic syndrome. Clin Exp Dermatol 30:141\u2013145","journal-title":"Clin Exp Dermatol"},{"key":"507_CR86","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2133.2002.48901.x","volume":"147","author":"L Beretta","year":"2002","unstructured":"Beretta L, Caronni M, Vanoli M, Scorza R (2002) Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders. Br J Dermatol 147:385\u2013386","journal-title":"Br J Dermatol"},{"key":"507_CR87","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0248-8663(97)89298-3","volume":"18","author":"O Hall\u00e9","year":"1997","unstructured":"Hall\u00e9 O, Schaeverbeke T, Bannwarth B, Dehais J (1997) Les facteurs d\u2019environnement et les \u00e9l\u00e9ments iatrog\u00e8nes dans la scl\u00e9rodermie syst\u00e9mique et les syndromes apparent\u00e9s. Revue de la litt\u00e9rature. Rev Med Interne 18:219\u2013229","journal-title":"Rev Med Interne"},{"key":"507_CR88","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1365-2133.2002.488210.x","volume":"147","author":"S L\u00e4uchli","year":"2002","unstructured":"L\u00e4uchli S, Tr\u00fceb RM, Fehr M, Hafner J (2002) Scleroderma-like drug reaction to paclitaxel (Taxol). Br J Dermatol 147:619\u2013621","journal-title":"Br J Dermatol"},{"key":"507_CR89","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1046\/j.1365-2133.2000.03448.x","volume":"142","author":"I Marie","year":"2000","unstructured":"Marie I, Levesque H, Plissonnier D, Balguerie X, Cailleux N, Courtois H (2000) Digital necrosis related to cisplatin in systemic sclerosis. Br J Dermatol 142:833\u2013834","journal-title":"Br J Dermatol"},{"key":"507_CR90","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2133.2006.07579.x","volume":"156","author":"I Marie","year":"2007","unstructured":"Marie I, Joly P, Courville P, Levesqsue H (2007) Pseudosystemic sclerosis as a complication of recombinant human interleukin 2 (aldesleukin) therapy. Br J Dermatol 156:182\u2013183","journal-title":"Br J Dermatol"},{"key":"507_CR91","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0300-483X(02)00051-3","volume":"174","author":"T Vial","year":"2002","unstructured":"Vial T, Choquet-Kastylevsky G, Descotes J (2002) Adverse effects of immunotherapeutics involving the immune system. Toxicology 174:3\u201311","journal-title":"Toxicology"},{"key":"507_CR92","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00002018-200730010-00004","volume":"30","author":"B Bannwarth","year":"2007","unstructured":"Bannwarth B (2007) Drug-induced musculoskeletal disorders. Drug Saf 30:27\u201346","journal-title":"Drug Saf"},{"key":"507_CR93","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0738-081X(98)00006-6","volume":"16","author":"UF Haustein","year":"1998","unstructured":"Haustein UF, Haupt B (1998) Drug-induced scleroderma and sclerodermiform conditions. Clin Dermatol 16:353\u2013366","journal-title":"Clin Dermatol"},{"key":"507_CR94","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1440-0960.1996.tb00994.x","volume":"37","author":"BK Pang","year":"1996","unstructured":"Pang BK, Munro V, Kossard S (1996) Pseudoscleroderma secondary to phytomenadione (vitamin K1) injections: Texier\u2019s disease. Australas J Dermatol 37:44\u201347","journal-title":"Australas J Dermatol"},{"key":"507_CR95","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0049-0172(97)80022-4","volume":"26","author":"WD Blackburn Jr","year":"1997","unstructured":"Blackburn WD Jr (1997) Eosinophilia myalgia syndrome. Semin Arthritis Rheum 26:788\u2013793","journal-title":"Semin Arthritis Rheum"},{"key":"507_CR96","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.berh.2003.11.002","volume":"17","author":"S Guis","year":"2003","unstructured":"Guis S, Matt\u00e9i JP, Liot\u00e9 F (2003) Drug-induced and toxic myopathies. Best Pract Res Clin Rheumatol 17:877\u2013907","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"507_CR97","doi-asserted-by":"crossref","first-page":"851","DOI":"10.7326\/0003-4819-122-11-199506010-00008","volume":"122","author":"PA Hertzman","year":"1995","unstructured":"Hertzman PA, Clauw DJ, Kaufman LD, Varga J, Silver RM, Thacker HL, Mease P, Espinoza LR, Pincus T (1995) The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset. Ann Intern Med 122:851\u2013855","journal-title":"Ann Intern Med"},{"key":"507_CR98","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.0954-6820.1950.tb09614.x","volume":"136","author":"AP Skouby","year":"1949","unstructured":"Skouby AP (1949) Sclerodermia-like picture following a single serum injection. Acta Med Scand 136:51\u201355","journal-title":"Acta Med Scand"},{"key":"507_CR99","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2010.09.010","volume":"10","author":"C Grossman","year":"2011","unstructured":"Grossman C, Dovrish Z, Shoenfeld Y, Amital H (2011) Do infections facilitate the emergence of systemic sclerosis? Autoimmun Rev 10:244\u2013247","journal-title":"Autoimmun Rev"},{"key":"507_CR100","first-page":"267","volume":"17","author":"C Ferri","year":"1999","unstructured":"Ferri C, Longombardo G, Azzi A, Zakrzewska K (1999) Parvovirus B19 and systemic sclerosis. Clin Exp Rheumatol 17:267\u2013268","journal-title":"Clin Exp Rheumatol"},{"key":"507_CR101","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2141.1995.tb05427.x","volume":"91","author":"Y Yoto","year":"1995","unstructured":"Yoto Y, Kudoh T, Haseyama K, Suzuki N, Oda T, Katoh T, Takahashi T, Sekiguchi S, Chiba S (1995) Incidence of human parvovirus B19 DNA detection in blood donors. Br J Haematol 91:1017\u20131018","journal-title":"Br J Haematol"},{"key":"507_CR102","first-page":"718","volume":"17","author":"C Ferri","year":"1999","unstructured":"Ferri C, Zakrzewska K, Longombardo G, Giuggioli D, Storino FA, Pasero G, Azzi A (1999) Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol 17:718\u2013720","journal-title":"Clin Exp Rheumatol"},{"key":"507_CR103","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/(SICI)1096-9071(199711)53:3<229::AID-JMV8>3.0.CO;2-A","volume":"53","author":"P Cassinotti","year":"1997","unstructured":"Cassinotti P, Burtonboy G, Fopp M, Siegl G (1997) Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 53:229\u2013232","journal-title":"J Med Virol"},{"key":"507_CR104","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.0303-6987.2003.0143.x","volume":"31","author":"CM Magro","year":"2004","unstructured":"Magro CM, Nuovo G, Ferri C, Crowson AN, Giuggioli D, Sebastiani M (2004) Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma. J Cutan Pathol 31:43\u201350","journal-title":"J Cutan Pathol"},{"key":"507_CR105","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1128\/JVI.73.10.8762-8770.1999","volume":"73","author":"N Sol","year":"1999","unstructured":"Sol N, Le Junter J, Vassias I, Freyssinier JM, Thomas A, Prigent AF, Rudkin BB, Fichelson S, Morinet F (1999) Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 73:8762\u20138770","journal-title":"J Virol"},{"key":"507_CR106","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/art.10346","volume":"46","author":"C Ferri","year":"2002","unstructured":"Ferri C, Giuggioli D, Sebastiani M, Panfilo S, Abatangelo G, Zakrzewska K, Azzi A (2002) Parvovirus B19 infection of cultured skin fibroblasts from systemic sclerosis patients: comment on the article by Ray et al. Arthritis Rheum 46:2262\u20132263, author reply 2263\u20134","journal-title":"Arthritis Rheum"},{"key":"507_CR107","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/1529-0131(199801)41:1<10::AID-ART2>3.0.CO;2-P","volume":"41","author":"JP Pandey","year":"1998","unstructured":"Pandey JP, LeRoy EC (1998) Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis. Arthritis Rheum 41:10\u201315","journal-title":"Arthritis Rheum"},{"key":"507_CR108","first-page":"821","volume":"27","author":"JH Vaughan","year":"2000","unstructured":"Vaughan JH, Shaw PX, Nguyen MD, Medsger TA Jr, Wright TM, Metcalf JS, Leroy EC (2000) Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins. J Rheumatol 27:821\u2013823","journal-title":"J Rheumatol"},{"key":"507_CR109","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s007050050063","volume":"142","author":"S Shahgasempour","year":"1997","unstructured":"Shahgasempour S, Woodroffe SB, Sullivan-Tailyour G, Garnett HM (1997) Alteration in the expression of endothelial cell integrin receptors alpha 5 beta 1 and alpha 2 beta 1 and alpha 6 beta 1 after in vitro infection with a clinical isolate of human cytomegalovirus. Arch Virol 142:125\u2013138","journal-title":"Arch Virol"},{"key":"507_CR110","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3748\/wjg.v20.i6.1510","volume":"20","author":"E Magen","year":"2014","unstructured":"Magen E, Delgado JS (2014) Helicobacter pylori and skin autoimmune diseases. World J Gastroenterol 20:1510\u20131516","journal-title":"World J Gastroenterol"},{"key":"507_CR111","first-page":"1568","volume":"27","author":"S Danese","year":"2000","unstructured":"Danese S, Zoli A, Cremonini F, Gasbarrini A (2000) High prevalence of Helicobacter pylori type I virulent strains in patients with systemic sclerosis. J Rheumatol 27:1568\u20131569","journal-title":"J Rheumatol"},{"key":"507_CR112","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1523-5378.2002.00092.x","volume":"7","author":"L Kalabay","year":"2002","unstructured":"Kalabay L, Fekete B, Czirj\u00e1k L, Horv\u00e1th L, Daha MR, Veres A, F\u00f3nyad G, Horv\u00e1th A, Viczi\u00e1n A, Singh M, Hoffer I, F\u00fcst G, Romics L, Proh\u00e1szka Z (2002) Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 7:250\u2013256","journal-title":"Helicobacter"},{"key":"507_CR113","first-page":"650","volume":"25","author":"N Yazawa","year":"1998","unstructured":"Yazawa N, Fujimoto M, Kikuchi K, Kubo M, Ihn H, Sato S, Tamaki T, Tamaki K (1998) High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. J Rheumatol 25:650\u2013653","journal-title":"J Rheumatol"},{"key":"507_CR114","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/rheumatology\/keq137","volume":"49","author":"M Radi\u0107","year":"2010","unstructured":"Radi\u0107 M, Martinovi\u0107 Kaliterna D, Bonacin D, Morovi\u0107 Vergles J, Radi\u0107 J (2010) Correlation between Helicobacter pylori infection and systemic sclerosis activity. Rheumatology (Oxford) 49:1784\u20131785","journal-title":"Rheumatology (Oxford)"},{"key":"507_CR115","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2958.1993.tb01724.x","volume":"9","author":"G Macchia","year":"1993","unstructured":"Macchia G, Massone A, Burroni D, Covacci A, Censini S, Rappuoli R (1993) The Hsp60 protein of Helicobacter pylori: structure and immune response in patients with gastroduodenal diseases. Mol Microbiol 9:645\u2013652","journal-title":"Mol Microbiol"},{"key":"507_CR116","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005792-199309000-00001","volume":"72","author":"A Alonso-Ruiz","year":"1993","unstructured":"Alonso-Ruiz A, Calabozo M, Perez-Ruiz F, Mancebo L (1993) Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients. Medicine (Baltimore) 72:285\u2013295","journal-title":"Medicine (Baltimore)"},{"key":"507_CR117","first-page":"179","volume-title":"Diagnostics difficiles en M\u00e9decine interne","author":"I Marie","year":"2008","unstructured":"Marie I (2008) Connectivites et pseudo-connectivites d\u2019origine m\u00e9dicamenteuse et toxique. In: Rousset H, Vital Durand D, Dupond JL, Pavic M (eds) Diagnostics difficiles en M\u00e9decine interne, 3rd edn. Maloine, Paris, pp 179\u2013196","edition":"3"},{"key":"507_CR118","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/oxfordjournals.epirev.a000804","volume":"23","author":"M Posada de la Paz","year":"2001","unstructured":"Posada de la Paz M, Philen RM, Borda AI (2001) Toxic oil syndrome: the perspective after 20 years. Epidemiol Rev 23:231\u2013247","journal-title":"Epidemiol Rev"},{"key":"507_CR119","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1002\/art.30514","volume":"63","author":"JA Allen","year":"2011","unstructured":"Allen JA, Peterson A, Sufit R, Hinchcliff ME, Mahoney JM, Wood TA, Miller FW, Whitfield ML, Varga J (2011) Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan. Arthritis Rheum 63:3633\u20133639","journal-title":"Arthritis Rheum"},{"key":"507_CR120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3945\/an.110.1004","volume":"1","author":"SW Choi","year":"2010","unstructured":"Choi SW, Friso S (2010) Epigenetics: a new bridge between nutrition and health. Adv Nutr 1:8\u201316","journal-title":"Adv Nutr"},{"key":"507_CR121","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.revmed.2014.04.002","volume":"35","author":"I Marie","year":"2014","unstructured":"Marie I (2014) Scl\u00e9rodermie syst\u00e9mique et exposition professionnelle : vers une extension de la reconnaissance de maladie professionnelle en 2014 ? Rev Med Interne 35:631\u2013635","journal-title":"Rev Med Interne"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-015-0507-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-015-0507-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-015-0507-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T13:50:23Z","timestamp":1599227423000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-015-0507-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,4]]},"references-count":121,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["507"],"URL":"https:\/\/doi.org\/10.1007\/s00281-015-0507-3","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,4]]}}}